Lang Lv

机构：Buchang Pharma (China), Chinese Academy of Agricultural Sciences, Institute of Animal Sciences, Innovation Team (China), Ministry of Agriculture and Rural Affairs

发表论文 7 篇 · 总被引 208 次 · h-index 3

代表论文

• Efficacy and safety of Xiyanping injection in the treatment of COVID ‐19: A multicenter, prospective, open‐label and randomized controlled trial (2021 · Phytotherapy Research · 被引 103)
• Is combined medication with natural medicine a promising therapy for bacterial biofilm infection? (2020 · Biomedicine & Pharmacotherapy · 被引 69)
• Andrographolide Sulfonate Is a Promising Treatment to Combat Methicillin-resistant Staphylococcus aureus and Its Biofilms (2021 · Frontiers in Pharmacology · 被引 29)
• Single-Cell Transcriptome Profiling Reveals the Immune Dysregulation Characteristics of Mice Infected With Brucella abortus (2025 · The Journal of Infectious Diseases · 被引 2)
• A first-in-human phase I study to evaluate the safety, tolerability, and pharmacokinetics of a novel anti-influenza agent suraxavir marboxil in healthy Chinese subjects (2025 · Antimicrobial Agents and Chemotherapy · 被引 2)
• The Induction and Characterization of a Potential Rough‐Type Brucella Vaccine Candidate Strain RA343, and Its Safety, Protective Efficacy in Mouse and Guinea Pig Models (2025 · Animal Research and One Health · 被引 2)